HIV Drug Market - Forecast(2024 - 2030)

Report Code: HCR 23948 Report Format: PDF + Excel
1. HIV Drug Market - Overview
        1.1 Definitions and Scope
2. HIV Drug Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. HIV Drug Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. HIV Drug Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. HIV Drug Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. HIV Drug Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. HIV Drug Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. HIV Drug Market - By Product Type (Market Size -$Million / $Billion)
9. HIV Drug Market - By Medication Class (Market Size -$Million / $Billion)
9.1 Multi-Class Combination Drug
9.2 Nucleoside Reverse Transcriptase Inhibitor
9.3 Nonnucleoside Reverse Transcriptase Inhibitor
9.4 Protease Inhibitor
9.5 Fusion Inhibitor
9.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist
9.7 Hiv Integrase Strand Transfer Inhibitor
10. HIV Drug - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. HIV Drug- By Geography (Market Size -$Million / $Billion)
        11.1 HIV Drug Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 HIV Drug- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 HIV Drug- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 HIV Drug - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 HIV Drug - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. HIV Drug Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. HIV Drug Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. HIV Drug Market - Key Company List by Country Premium
15. HIV Drug Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Abbvie
        15.3 Boehringer Ingelheim International Gmbh
        15.4 Bristol-Myers Squibb
        15.5 Cipla
        15.6 F. Hoffmann-La Roche Ltd
        15.7 Gilead Sciences, Inc
        15.8 Johnson Johnson
        15.9 Merck Co , Inc
        15.10 Teva Pharmaceutical Industry Ltd
        15.11 Viiv Healthcare
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. HIV Drug Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. HIV Drug Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
1.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Global Industry Research
1.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
1.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.4 Protease Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.5 Fusion Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Global Industry Research
1.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Global Industry Research
2.Global Hiv Drug Market, By Medication Class Market 2023-2030 (Volume/Units)
2.1 Multi-Class Combination Drug Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Key Growth Factor And Opportunity Market 2023-2030 (Volume/Units)
2.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
2.4 Protease Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
2.5 Fusion Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
2.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 (Volume/Units) - Global Industry Research
2.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
3.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
3.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
3.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
3.4 Protease Inhibitor Market 2023-2030 ($M) - Regional Industry Research
3.5 Fusion Inhibitor Market 2023-2030 ($M) - Regional Industry Research
3.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Regional Industry Research
3.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Regional Industry Research
4.South America Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
4.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
4.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
4.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
4.4 Protease Inhibitor Market 2023-2030 ($M) - Regional Industry Research
4.5 Fusion Inhibitor Market 2023-2030 ($M) - Regional Industry Research
4.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Regional Industry Research
4.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Regional Industry Research
5.Europe Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
5.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
5.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
5.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
5.4 Protease Inhibitor Market 2023-2030 ($M) - Regional Industry Research
5.5 Fusion Inhibitor Market 2023-2030 ($M) - Regional Industry Research
5.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Regional Industry Research
5.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Regional Industry Research
6.APAC Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
6.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
6.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
6.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
6.4 Protease Inhibitor Market 2023-2030 ($M) - Regional Industry Research
6.5 Fusion Inhibitor Market 2023-2030 ($M) - Regional Industry Research
6.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Regional Industry Research
6.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.MENA Hiv Drug Market, By Medication Class Market 2023-2030 ($M)
7.1 Multi-Class Combination Drug Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Key Growth Factor And Opportunity Market 2023-2030 ($M)
7.2 Nucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.3 Nonnucleoside Reverse Transcriptase Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.4 Protease Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.5 Fusion Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.6 Entry Inhibitors-Ccr5 Co-Receptor Antagonist Market 2023-2030 ($M) - Regional Industry Research
7.7 Hiv Integrase Strand Transfer Inhibitor Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US HIV Drug Market Revenue, 2023-2030 ($M)
2.Canada HIV Drug Market Revenue, 2023-2030 ($M)
3.Mexico HIV Drug Market Revenue, 2023-2030 ($M)
4.Brazil HIV Drug Market Revenue, 2023-2030 ($M)
5.Argentina HIV Drug Market Revenue, 2023-2030 ($M)
6.Peru HIV Drug Market Revenue, 2023-2030 ($M)
7.Colombia HIV Drug Market Revenue, 2023-2030 ($M)
8.Chile HIV Drug Market Revenue, 2023-2030 ($M)
9.Rest of South America HIV Drug Market Revenue, 2023-2030 ($M)
10.UK HIV Drug Market Revenue, 2023-2030 ($M)
11.Germany HIV Drug Market Revenue, 2023-2030 ($M)
12.France HIV Drug Market Revenue, 2023-2030 ($M)
13.Italy HIV Drug Market Revenue, 2023-2030 ($M)
14.Spain HIV Drug Market Revenue, 2023-2030 ($M)
15.Rest of Europe HIV Drug Market Revenue, 2023-2030 ($M)
16.China HIV Drug Market Revenue, 2023-2030 ($M)
17.India HIV Drug Market Revenue, 2023-2030 ($M)
18.Japan HIV Drug Market Revenue, 2023-2030 ($M)
19.South Korea HIV Drug Market Revenue, 2023-2030 ($M)
20.South Africa HIV Drug Market Revenue, 2023-2030 ($M)
21.North America HIV Drug By Application
22.South America HIV Drug By Application
23.Europe HIV Drug By Application
24.APAC HIV Drug By Application
25.MENA HIV Drug By Application
26.Boehringer Ingelheim International Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bristol-Myers Squibb, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Gilead Sciences, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Viiv Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hoffmann-La Roche Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Abbvie, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Cipla, Sales /Revenue, 2015-2018 ($Mn/$Bn)